Using Practice Facilitation in Primary Care Settings to Reduce Risk Factors for Cardiovascular Disease
| Status: | Active, not recruiting |
|---|---|
| Conditions: | High Blood Pressure (Hypertension), Peripheral Vascular Disease |
| Therapuetic Areas: | Cardiology / Vascular Diseases |
| Healthy: | No |
| Age Range: | 18 - 85 |
| Updated: | 8/26/2018 |
| Start Date: | August 2015 |
| End Date: | April 2019 |
The primary purpose of this study is to evaluate the effectiveness of practice facilitation
as a quality improvement strategy for implementing the Million Hearts' ABCS treatment
guidelines for reducing cardiovascular disease (CVD) among high-risk patients who receive
care in primary care practices in New York City. The ABCS refer to the following: Aspirin in
high-risk individuals (A), Blood pressure control and management (B), Cholesterol management
(C), and Smoking cessation (S). The long-term goal is to create a robust infrastructure to
disseminate and implement evidence based practice guidelines (EBPG) findings in primary care
practices and improve practices' capacity to receive and implement other EBPG findings in the
future.
as a quality improvement strategy for implementing the Million Hearts' ABCS treatment
guidelines for reducing cardiovascular disease (CVD) among high-risk patients who receive
care in primary care practices in New York City. The ABCS refer to the following: Aspirin in
high-risk individuals (A), Blood pressure control and management (B), Cholesterol management
(C), and Smoking cessation (S). The long-term goal is to create a robust infrastructure to
disseminate and implement evidence based practice guidelines (EBPG) findings in primary care
practices and improve practices' capacity to receive and implement other EBPG findings in the
future.
Inclusion Criteria:
Provider and staff eligibility inclusion criteria.
- Eligibility includes working full or part time at the study site.
Stakeholder eligibility inclusion criteria.
- Steering committee members or other key stakeholder from the following groups: Health
Plan Chief Medical Officer, State health officials in the Chronic Disease Program, and
leadership from relevant national associations (American Heart Association), members
of Advisory Board of CHCANYS (these are physician leaders).
Patient eligibility inclusion criteria:
- at least one of the ABCS risk factors for CVD (i.e., hypertension, hyperlipidemia,
eligible for aspirin and/or is a current smoker)
- must have received care at the clinic for at least 12 months
- Patients eligible for aspirin are those with a documented ICD-9 code for ischemic
vascular disease in the last 12 months. Similarly, patients with a diagnosis of
hypertension and/or hyperlipidemia will have a documented ICD-9 code for the targeted
risk factor
- Smokers will be identified by a documented ICD-9 code, prescription for a cessation
medication in the last 12 months or documentation in the chart (e.g. meaningful use
measure) during the last 12 months (see outcome measures)
We found this trial at
1
site
550 1st Ave
New York, New York 10016
New York, New York 10016
(212) 263-7300
Principal Investigator: Donna Shelley, MD
New York University School of Medicine NYU School of Medicine has a proud history that...
Click here to add this to my saved trials
